Efficacy of ranibizumab and aflibercept on reducing maximum diameter of largest cyst in diabetic cystoid macular edema: MARMASIA study group
PurposeThis study aimed to compare the effect of intravitreal aflibercept (IVA) and ranibizumab (IVR) on the maximal diameter of the largest intraretinal cyst (mdIRC), indicating chronicity in patients with diabetic cystoid macular edema (CME).MethodsThis retrospective, comparative study included a subgroup of patients from the MARMASIA Study with treatment-naïve diabetic CME who had IVA (IVA group) or IVR (IVR group) on a pro re nata regimen after a loading dose of 3-monthly injections and followed-up for 24 months. Best-corrected visual acuity (logMAR), central macular thickness (CMT, µm), and mdIRC (µm) and their changes during the study period in the IVA and IVR groups were compared.ResultsA total of 175 eyes (65 [37.1%] in IVA and 110 [62.9%] in IVR group) of 113 patients were included in the study analysis. Both groups had statistically significant improvements in BCVA and CMT during the follow-up (p < 0.05 for all), which were comparable between the groups at each time point. However, the mean reduction in mdIRCs was consistently and significantly higher in the IVA group compared to the IVR group at each follow-up examination (F[1, 3.52] = 6.93, p = 0.009).ConclusionIVA seems to have a greater impact in reducing cyst sizes than IVR in diabetic CME.
Authors
- Utku Limon (ORCID: https://orcid.org/0000-0002-4998-1896)
- Nursal Melda Yenerel (ORCID: https://orcid.org/0000-0001-9940-8599)
- Işıl Kutlutürk Karagöz (ORCID: https://orcid.org/0000-0001-7367-2906)
- Ayşe Sönmez (ORCID: https://orcid.org/0000-0003-0523-5979)
- Hatice Selen Kanar (ORCID: https://orcid.org/0000-0001-6505-9714)
- Esra Türkseven Kumral (ORCID: https://orcid.org/0000-0001-6285-6566)
- Ecem Önder Tokuç (ORCID: https://orcid.org/0000-0002-6260-6716)
- Erdinç Bozkurt (ORCID: https://orcid.org/0000-0002-5570-799X)
- Mehmet Orkun Sevik (ORCID: https://orcid.org/0000-0001-7130-4798)
- Tuğba Aydoğan Gezginaslan (ORCID: https://orcid.org/0000-0002-2624-7496)
- V. Levent Karabaş (ORCID: https://orcid.org/0000-0001-7860-4603)
- Nimet Yeşim Erçalık (ORCID: https://orcid.org/0000-0002-8730-2495)
- Fatih Bilgehan Kaplan (ORCID: https://orcid.org/0000-0001-7580-5514)
- Banu Öncel (ORCID: https://orcid.org/0000-0002-6791-2915)
- Aslan Aykut (ORCID: https://orcid.org/0000-0001-5426-1992)
- Işılay Özsoy Saygın (ORCID: https://orcid.org/0000-0003-0101-1900)
- Özlem Aydın Öncü (ORCID: https://orcid.org/0000-0001-7299-9528)
- Uğur Yayla (ORCID: https://orcid.org/0000-0002-0073-4747)
- Abdullah Özkaya (ORCID: https://orcid.org/0000-0002-1940-8669)
- Özlem Şahin (ORCID: https://orcid.org/0000-0003-2907-2852)
- Erkan Çelik (ORCID: https://orcid.org/0000-0002-8681-7868)
- Ece Başaran Emengen (ORCID: https://orcid.org/0000-0003-4894-7116)
Institutions
- Sakarya University (TR)
- Dr Lütfi Kırdar Kartal Eğitim ve Araştırma Hastanesi (TR)
- Ümraniye Eğitim ve Araştırma Hastanesi (TR)
- Memorial Sisli Hospital (TR)
- Haydarpaşa Numune Eğitim ve Araştırma Hastanesi (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Fatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi (TR)
- Kocaeli Üniversitesi (TR)
- Marmara University (TR)
Publication Details
- Journal
- European Journal of Ophthalmology
- Published
- 2024-09-05
- DOI
- https://doi.org/10.1177/11206721241280737
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00